_HOME | _RSS
_TRSSARTICLE
LDL Cholesterol Level Predicts HCV Therapy Response in Patients With HIV Coinfection
Dienstag, 24. Juni 2008, 07:57 Uhr - 6 Monate, 2 Wochen her - Presse spécialisée - Medscape HIV AIDS
Patients coinfected with hepatitis C virus (HCV) and HIV who have high pretreatment LDL cholesterol levels are more likely to respond to HCV therapy than are similar patients with low LDL cholesterol levels, according to a report in the May 11th issue of AIDS. Reuters Health Information
